Pluri Inc (PLUR)
5.38
-0.07
(-1.28%)
USD |
NASDAQ |
Nov 15, 16:00
5.35
-0.03
(-0.56%)
After-Hours: 20:00
Pluri Revenue (TTM): 0.326M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 0.326M |
March 31, 2024 | 0.341M |
December 31, 2023 | 0.357M |
September 30, 2023 | 0.254M |
June 30, 2023 | 0.287M |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 |
Date | Value |
---|---|
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 3.036M |
September 30, 2015 | 0.379M |
June 30, 2015 | 0.379M |
March 31, 2015 | 0.379M |
December 31, 2014 | 0.379M |
September 30, 2014 | 0.379M |
June 30, 2014 | 0.379M |
March 31, 2014 | 0.38M |
December 31, 2013 | 0.479M |
September 30, 2013 | 0.579M |
June 30, 2013 | 0.679M |
March 31, 2013 | 0.685M |
December 31, 2012 | 0.721M |
September 30, 2012 | 0.757M |
June 30, 2012 | 0.716M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.254M
Minimum
Sep 2023
0.357M
Maximum
Dec 2023
0.313M
Average
0.326M
Median
Jun 2024
Revenue (TTM) Benchmarks
InspireMD Inc | 6.821M |
IDenta Corp | 1.210M |
BiomX Inc | -- |
IR-Med Inc | -- |
Raphael Pharmaceutical Inc | -- |